Clinical Trials Browser

Withdrawn × OTHER × Rosiglitazone × Clear all

NCT00084578 2013-07-15

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Phase NA Withdrawn

Urinary Bladder Neoplasms